ETF Holdings Breakdown of AMPH

AMPH institutional holdings

Date	ETF ISIN/Name	Num Shares	Book value
2025-10-17	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	4,479	USD 106,511
2025-10-17	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	29,226	USD 694,994
2025-10-17	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	29,226	USD 694,994
2025-10-17	IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc))	29,797	USD 708,573
2025-10-17	IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc))	218	USD 5,184
Total =		92,946	USD 2,210,256

Book value of shares is calculated on the adjusted close price of each day (row).

News associated with AMPH

Amphastar Pharmaceuticals (NASDAQ:AMPH) Given New $32.00 Price Target at Bank of America

Amphastar Pharmaceuticals (NASDAQ:AMPH – Free Report) had its target price upped by Bank of America from $28.00 to $32.00 in a research report report published on Tuesday,Benzinga reports. They currently have a neutral rating on the stock. Several other research firms also recently weighed in on AMPH. JPMorgan Chase & Co. reissued a “neutral” rating […] - 2025-08-27 02:52:54

Amphastar Pharmaceuticals (NASDAQ:AMPH) vs. Personalis (NASDAQ:PSNL) Financial Contrast

Amphastar Pharmaceuticals (NASDAQ:AMPH – Get Free Report) and Personalis (NASDAQ:PSNL – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, risk, dividends, valuation and earnings. Volatility and Risk Amphastar Pharmaceuticals has a beta […] - 2025-08-20 02:55:13

Piper Sandler Cuts Amphastar Pharmaceuticals (NASDAQ:AMPH) Price Target to $25.00

Amphastar Pharmaceuticals (NASDAQ:AMPH – Free Report) had its price target trimmed by Piper Sandler from $30.00 to $25.00 in a report issued on Friday morning,Benzinga reports. The brokerage currently has a neutral rating on the stock. Other analysts have also issued reports about the stock. Needham & Company LLC reissued a “hold” rating on shares […] - 2025-08-11 03:08:44

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Stake Raised by Victory Capital Management Inc.

Victory Capital Management Inc. grew its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 27.9% in the first quarter, Holdings Channel.com reports. The fund owned 81,087 shares of the company’s stock after buying an additional 17,700 shares during the quarter. Victory Capital Management Inc.’s holdings in Amphastar Pharmaceuticals were worth $2,351,000 […] - 2025-07-29 04:20:54

New York State Common Retirement Fund Acquires 11,075 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)

New York State Common Retirement Fund lifted its stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 15.7% in the 1st quarter, HoldingsChannel reports. The institutional investor owned 81,565 shares of the company’s stock after purchasing an additional 11,075 shares during the quarter. New York State Common Retirement Fund’s holdings in Amphastar Pharmaceuticals were […] - 2025-07-24 04:40:46

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 493,214 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lessened its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 85.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 83,231 shares of the company’s […] - 2025-06-06 04:42:49

Squarepoint Ops LLC Buys 11,929 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)

Squarepoint Ops LLC grew its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 208.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 17,664 shares of the company’s stock after purchasing an additional 11,929 shares during the period. Squarepoint Ops […] - 2025-06-03 05:38:56

Nuveen Asset Management LLC Sells 112,307 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)

Nuveen Asset Management LLC trimmed its position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 54.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 95,665 shares of the company’s stock after selling 112,307 shares during the quarter. Nuveen Asset Management LLC’s holdings […] - 2025-06-02 05:04:53

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by Two Sigma Investments LP

Two Sigma Investments LP lowered its position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 0.6% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 98,184 shares of the company’s stock after selling 614 shares during the quarter. Two Sigma Investments LP’s holdings in Amphastar Pharmaceuticals were worth $3,646,000 as of […] - 2025-05-29 05:14:54

Two Sigma Advisers LP Sells 12,400 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)

Two Sigma Advisers LP lessened its position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 12.6% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 85,900 shares of the company’s stock after selling 12,400 shares during the period. Two Sigma Advisers LP’s holdings in Amphastar Pharmaceuticals were worth $3,189,000 as of its most […] - 2025-05-27 05:57:02

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by The Manufacturers Life Insurance Company

The Manufacturers Life Insurance Company trimmed its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 2.8% in the 4th quarter, HoldingsChannel reports. The firm owned 21,257 shares of the company’s stock after selling 610 shares during the period. The Manufacturers Life Insurance Company’s holdings in Amphastar Pharmaceuticals were worth $789,000 as […] - 2025-05-15 04:45:07

Northern Trust Corp Purchases 29,808 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)

Northern Trust Corp raised its position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 5.1% in the fourth quarter, HoldingsChannel reports. The firm owned 613,170 shares of the company’s stock after acquiring an additional 29,808 shares during the period. Northern Trust Corp’s holdings in Amphastar Pharmaceuticals were worth $22,767,000 as of its […] - 2025-05-13 05:28:51

Hsbc Holdings PLC Boosts Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)

Hsbc Holdings PLC lifted its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 23.4% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 8,991 shares of the company’s stock after purchasing an additional 1,707 shares during the quarter. […] - 2025-05-09 05:41:01

First Trust Advisors LP Raises Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)

First Trust Advisors LP boosted its stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 350.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 81,129 shares of the company’s stock after purchasing an additional 63,100 shares during the quarter. […] - 2025-05-04 05:30:50

Barclays PLC Acquires 10,334 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)

Barclays PLC lifted its holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 13.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 84,790 shares of the company’s stock after acquiring an additional 10,334 shares during the period. Barclays PLC’s holdings […] - 2025-04-30 05:12:50

Raymond James Financial Inc. Invests $3.45 Million in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)

Raymond James Financial Inc. purchased a new stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 92,904 shares of the company’s stock, valued at approximately $3,450,000. Raymond James Financial Inc. owned approximately 0.19% of Amphastar […] - 2025-04-28 05:06:47

Vanguard Group Inc. Has $100.79 Million Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)

Vanguard Group Inc. increased its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 0.1% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 2,714,628 shares of the company’s stock after acquiring an additional 3,155 shares during the quarter. Vanguard Group Inc. owned 0.06% of Amphastar Pharmaceuticals worth $100,794,000 as of […] - 2025-04-10 04:38:49

American Century Companies Inc. Decreases Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)

American Century Companies Inc. lessened its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 26.2% in the fourth quarter, Holdings Channel.com reports. The fund owned 472,017 shares of the company’s stock after selling 167,575 shares during the period. American Century Companies Inc.’s holdings in Amphastar Pharmaceuticals were worth $17,526,000 at the […] - 2025-04-01 05:38:53

Thrivent Financial for Lutherans Cuts Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)

Thrivent Financial for Lutherans reduced its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 2.8% during the fourth quarter, Holdings Channel reports. The institutional investor owned 28,988 shares of the company’s stock after selling 827 shares during the quarter. Thrivent Financial for Lutherans’ holdings in Amphastar Pharmaceuticals were worth $1,076,000 at […] - 2025-04-01 04:40:47

Victory Capital Management Inc. Sells 155,144 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)

Victory Capital Management Inc. cut its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 71.0% in the 4th quarter, Holdings Channel.com reports. The fund owned 63,387 shares of the company’s stock after selling 155,144 shares during the period. Victory Capital Management Inc.’s holdings in Amphastar Pharmaceuticals were worth $2,354,000 as of […] - 2025-03-18 05:41:08

AlphaQuest LLC Reduces Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)

AlphaQuest LLC reduced its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 35.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,862 shares of the company’s stock after selling 2,724 shares during the period. AlphaQuest […] - 2025-03-17 06:03:06

Smartleaf Asset Management LLC Buys 493 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)

Smartleaf Asset Management LLC grew its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 222.1% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 715 shares of the company’s stock after purchasing an additional 493 shares during the quarter. Smartleaf Asset Management LLC’s holdings in Amphastar Pharmaceuticals were worth $26,000 […] - 2025-03-13 05:54:49

Assetmark Inc. Decreases Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)

Assetmark Inc. reduced its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 4.5% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 41,921 shares of the company’s stock after selling 1,985 shares during the period. Assetmark Inc.’s holdings in Amphastar Pharmaceuticals were […] - 2025-03-11 06:20:51

Amphastar Pharmaceuticals (NASDAQ:AMPH) Lowered to “Neutral” Rating by Piper Sandler

Piper Sandler cut shares of Amphastar Pharmaceuticals (NASDAQ:AMPH – Free Report) from an overweight rating to a neutral rating in a research note issued to investors on Tuesday, Marketbeat reports. They currently have $36.00 price target on the stock, down from their previous price target of $66.00. A number of other equities research analysts also […] - 2025-02-05 06:38:50

Back to Listing

Disclaimer